UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report:
(Date of earliest event reported)
July 1, 2016
____________________________
MEDICAL IMAGING CORP.
(Exact name of registrant as specified in charter)
NEVADA
(State or other Jurisdiction of Incorporation or Organization)
| | |
333-1364363 | 848 N. Rainbow Blvd. #2494 Las Vegas, Nevada 89107 | 98-0493698 |
(Commission File Number) | (Address of Principal Executive Offices and zip code) | (IRS Employer Identification No.) |
(877) 331-3444
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into Material Definitive Agreement.
On July 1, 2016, Medical Imaging Corp. (the “Company”) sold to Assurance Funding Solutions $500,000 of future accounts receivables for $350,000. The Company will make monthly payments of $20,000 each to Assurance for a period of 25 months.
Proceeds from the sale were used primarily to retire some short term debts of the Company with the remainder for general working capital purposes.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| Medical Imaging Corp. |
| (Registrant) |
| | |
| | |
Dated: July 18, 2016 | By: | /s/ Mitchell Geisler |
| | Name: Mitchell Geisler |
| | Title: Chief Executive Officer |
3
